The UK market for systemic hormonal preparations, excluding sex hormones and insulins, shows a consistent upward trend from 2023 to 2028. In 2023, the market value stood at $11.26. From 2024 onwards, the market is projected to increase annually, with a steady growth rate. The year-on-year variation indicates a stable increase averaging around 0.85% per year, leading to a compound annual growth rate (CAGR) over the five-year period reaching approximately 0.84%.
Future trends to watch for in this sector include:
- The impact of technological advancements in drug delivery systems.
- Regulatory changes and healthcare policies in the UK.
- Market adaptation to innovative therapies and personalized medicine.
- Potential shifts due to demographic changes and aging populations.
